Monitoring gastrointestinal function to guide care of high risk patients
US6365128B1 · kind B1 · utility
6Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 1999 |
| Grant date | Apr 2, 2002 |
| Priority date | — |
| Expiry date | Dec 17, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/0004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of guiding the care of a critically ill patient or other high risk patient, said method comprising administering an effective dose of a gastric acid stimulant or suppressant agent and then measuring for an acute change in the gastric juice pH. A patient who demonstrates a significant change in the gastric juice pH using this test can have their medical care normalized in an accelerated fashion thereby reducing the duration, intensity, and cost of their care. Conversely, a patient who is not responsive is not ready for reduced support and may require more support.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.